These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 15118611)

  • 1. Functional role of matrix metalloproteinases in ovarian tumor cell plasticity.
    Sood AK; Fletcher MS; Coffin JE; Yang M; Seftor EA; Gruman LM; Gershenson DM; Hendrix MJ
    Am J Obstet Gynecol; 2004 Apr; 190(4):899-909. PubMed ID: 15118611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma.
    Seftor RE; Seftor EA; Koshikawa N; Meltzer PS; Gardner LM; Bilban M; Stetler-Stevenson WG; Quaranta V; Hendrix MJ
    Cancer Res; 2001 Sep; 61(17):6322-7. PubMed ID: 11522618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphoinositide 3-kinase regulates membrane Type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry.
    Hess AR; Seftor EA; Seftor RE; Hendrix MJ
    Cancer Res; 2003 Aug; 63(16):4757-62. PubMed ID: 12941789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proinvasive properties of ovarian cancer ascites-derived membrane vesicles.
    Graves LE; Ariztia EV; Navari JR; Matzel HJ; Stack MS; Fishman DA
    Cancer Res; 2004 Oct; 64(19):7045-9. PubMed ID: 15466198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibitory effects of matrix metalloproteinase (MMP) inhibitor LY52 on expression of MMP-2 and MMP-9 and invasive ability of human ovarian carcinoma cell line SKOV3].
    Yuan YX; Xu WF; Liu J; Chen MH; Meng H; Qu XJ
    Ai Zheng; 2006 Jun; 25(6):663-70. PubMed ID: 16764758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular determinants of ovarian cancer plasticity.
    Sood AK; Seftor EA; Fletcher MS; Gardner LM; Heidger PM; Buller RE; Seftor RE; Hendrix MJ
    Am J Pathol; 2001 Apr; 158(4):1279-88. PubMed ID: 11290546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibitory effect of MT1-MMP antisense nucleotide on invasion of human highly metastatic ovarian cancer cell line SW626].
    Wu MF; Liao GN; Jia P; Xi L; Lu YP; Ma D
    Ai Zheng; 2004 Nov; 23(11):1263-6. PubMed ID: 15522170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of tumor- and stromal-derived MT1-MMP expression with progression of human ovarian tumors in SCID mice.
    Drew AF; Blick TJ; Lafleur MA; Tim EL; Robbie MJ; Rice GE; Quinn MA; Thompson EW
    Gynecol Oncol; 2004 Dec; 95(3):437-48. PubMed ID: 15581944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
    Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
    Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2).
    Hess AR; Seftor EA; Gardner LM; Carles-Kinch K; Schneider GB; Seftor RE; Kinch MS; Hendrix MJ
    Cancer Res; 2001 Apr; 61(8):3250-5. PubMed ID: 11309274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
    Cheung LW; Leung PC; Wong AS
    Cancer Res; 2006 Nov; 66(22):10902-10. PubMed ID: 17108127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblasts stimulate human ovarian cancer cell invasion and expression of 72-kDa gelatinase A (MMP-2).
    Westerlund A; Hujanen E; Puistola U; Turpeenniemi-Hujanen T
    Gynecol Oncol; 1997 Oct; 67(1):76-82. PubMed ID: 9345360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct modes of collagen type I proteolysis by matrix metalloproteinase (MMP) 2 and membrane type I MMP during the migration of a tip endothelial cell: insights from a computational model.
    Karagiannis ED; Popel AS
    J Theor Biol; 2006 Jan; 238(1):124-45. PubMed ID: 16005020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The involvement of apoptosis in melanoma vasculogenic mimicry.
    Vartanian AA; Burova OS; Stepanova EV; Baryshnikov AY
    Melanoma Res; 2007 Feb; 17(1):1-8. PubMed ID: 17235236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dipeptidyl peptidase IV overexpression induces up-regulation of E-cadherin and tissue inhibitors of matrix metalloproteinases, resulting in decreased invasive potential in ovarian carcinoma cells.
    Kajiyama H; Kikkawa F; Khin E; Shibata K; Ino K; Mizutani S
    Cancer Res; 2003 May; 63(9):2278-83. PubMed ID: 12727850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Primary study of vasculogenic mimicry induced by hypoxia in epithelial ovarian carcinoma].
    Yao LQ; Feng YJ; Ding JX; Xu CJ; Jin HY; Yin LH
    Zhonghua Fu Chan Ke Za Zhi; 2005 Oct; 40(10):662-5. PubMed ID: 16277894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD), a novel actor in invasive growth, controls matrix metalloproteinase activity.
    Lunter PC; van Kilsdonk JW; van Beek H; Cornelissen IM; Bergers M; Willems PH; van Muijen GN; Swart GW
    Cancer Res; 2005 Oct; 65(19):8801-8. PubMed ID: 16204050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Elevated expression of matrix metalloproteinase-9, and fibronectin concentration in recurrent epithelial ovarian cancer].
    Demeter A; Szirmai K; Oláh J; Papp Z; Jeney A
    Orv Hetil; 2004 Aug; 145(31):1617-24. PubMed ID: 15384859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential role of tissue factor pathway inhibitors 1 and 2 in melanoma vasculogenic mimicry.
    Ruf W; Seftor EA; Petrovan RJ; Weiss RM; Gruman LM; Margaryan NV; Seftor RE; Miyagi Y; Hendrix MJ
    Cancer Res; 2003 Sep; 63(17):5381-9. PubMed ID: 14500372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focal adhesion kinase promotes the aggressive melanoma phenotype.
    Hess AR; Postovit LM; Margaryan NV; Seftor EA; Schneider GB; Seftor RE; Nickoloff BJ; Hendrix MJ
    Cancer Res; 2005 Nov; 65(21):9851-60. PubMed ID: 16267008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.